Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis
- PMID: 16473858
- PMCID: PMC1370968
- DOI: 10.1136/bmj.38731.532766.F6
Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis
Abstract
Objective: To conduct a systematic review of the efficacy and safety of exogenous melatonin in managing secondary sleep disorders and sleep disorders accompanying sleep restriction, such as jet lag and shiftwork disorder.
Data sources: 13 electronic databases and reference lists of relevant reviews and included studies; Associated Professional Sleep Society abstracts (1999 to 2003).
Study selection: The efficacy review included randomised controlled trials; the safety review included randomised and non-randomised controlled trials.
Quality assessment: Randomised controlled trials were assessed by using the Jadad Scale and criteria by Schulz et al, and non-randomised controlled trials by the Downs and Black checklist.
Data extraction and synthesis: One reviewer extracted data and another reviewer verified the data extracted. The inverse variance method was used to weight studies and the random effects model was used to analyse data.
Main results: Six randomised controlled trials with 97 participants showed no evidence that melatonin had an effect on sleep onset latency in people with secondary sleep disorders (weighted mean difference -13.2 (95% confidence interval -27.3 to 0.9) min). Nine randomised controlled trials with 427 participants showed no evidence that melatonin had an effect on sleep onset latency in people who had sleep disorders accompanying sleep restriction (-1.0 (-2.3 to 0.3) min). 17 randomised controlled trials with 651 participants showed no evidence of adverse effects of melatonin with short term use (three months or less).
Conclusions: There is no evidence that melatonin is effective in treating secondary sleep disorders or sleep disorders accompanying sleep restriction, such as jet lag and shiftwork disorder. There is evidence that melatonin is safe with short term use.
Figures
Comment in
-
Does melatonin help people sleep?BMJ. 2006 Feb 18;332(7538):373-4. doi: 10.1136/bmj.332.7538.373. BMJ. 2006. PMID: 16484240 Free PMC article. No abstract available.
-
Does melatonin improve sleep? Muddles with melatonin.BMJ. 2006 Mar 4;332(7540):550. doi: 10.1136/bmj.332.7540.550-a. BMJ. 2006. PMID: 16513723 Free PMC article. No abstract available.
-
Does melatonin improve sleep? Efficacy of melatonin.BMJ. 2006 Mar 4;332(7540):550. doi: 10.1136/bmj.332.7540.550. BMJ. 2006. PMID: 16513724 Free PMC article. No abstract available.
Similar articles
-
The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis.J Gen Intern Med. 2005 Dec;20(12):1151-8. doi: 10.1111/j.1525-1497.2005.0243.x. J Gen Intern Med. 2005. PMID: 16423108 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Pharmacotherapies for sleep disturbances in dementia.Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2020 Nov 15;11:CD009178. doi: 10.1002/14651858.CD009178.pub4. PMID: 27851868 Free PMC article. Updated. Review.
-
Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders.Sleep Med Rev. 2017 Aug;34:10-22. doi: 10.1016/j.smrv.2016.06.005. Epub 2016 Jul 20. Sleep Med Rev. 2017. PMID: 28648359 Review.
-
The use of MElatonin in children with neurodevelopmental disorders and impaired sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS).Health Technol Assess. 2012;16(40):i-239. doi: 10.3310/hta16400. Health Technol Assess. 2012. PMID: 23098680 Clinical Trial.
Cited by
-
Melatonin vs. dexmedetomidine for sleep induction in children before electroencephalography.Front Pediatr. 2024 Apr 25;12:1362918. doi: 10.3389/fped.2024.1362918. eCollection 2024. Front Pediatr. 2024. PMID: 38725985 Free PMC article.
-
Effects of open and closed skill exercise interventions on executive function in typical children: a meta-analysis.BMC Psychol. 2023 Nov 30;11(1):420. doi: 10.1186/s40359-023-01317-w. BMC Psychol. 2023. PMID: 38037184 Free PMC article.
-
MiR-126 and miR-146a as Melatonin-Responsive Biomarkers for Neonatal Brain Ischemia.J Mol Neurosci. 2023 Oct;73(9-10):763-772. doi: 10.1007/s12031-023-02155-6. Epub 2023 Sep 19. J Mol Neurosci. 2023. PMID: 37725287 Free PMC article.
-
Chorioamnionitis disrupts erythropoietin and melatonin homeostasis through the placental-fetal-brain axis during critical developmental periods.Front Physiol. 2023 Jul 20;14:1201699. doi: 10.3389/fphys.2023.1201699. eCollection 2023. Front Physiol. 2023. PMID: 37546540 Free PMC article.
-
Deregulated Brain's Central Clock Management on Sleep-Wake Behavior in Women With Polycystic Ovary Syndrome: Melatonin & Sleep Pattern.J Family Reprod Health. 2022 Dec;16(4):229-238. doi: 10.18502/jfrh.v16i4.11348. J Family Reprod Health. 2022. PMID: 37465433 Free PMC article. Review.
References
-
- National Institutes of Health. National Center on Sleep Disorders Research Plan. 2003. www.nhlbi.nih.gov/health/prof/sleep/res_plan/sleep-rplan.pdf (accessed 14 Jan 2006).
-
- Roller L. Treating sleep disorders. Austral J Pharm 2002;83: 443-7.
-
- Reiter RJ. Melatonin: clinical relevance. Best Pract Res Clin Endocrinol Metab 2003;17: 273-85. - PubMed
-
- Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al.. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials 1996;17: 1-12. - PubMed
-
- Schulz KF, Chalmers I, Hayes RJ, Altman D. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273: 408-12. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical